Mettler-Toledo International Stock Forecast, Price & News

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mettler-Toledo International in the last twelve months. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Mettler-Toledo International stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MTD, but not buy additional shares or sell existing shares.
View analyst ratings for Mettler-Toledo International or view top-rated stocks.

3 brokerages have issued 12 month price targets for Mettler-Toledo International's stock. Their MTD stock forecasts range from $1,240.00 to $1,595.00. On average, they predict Mettler-Toledo International's share price to reach $1,415.00 in the next year. This suggests a possible upside of 23.4% from the stock's current price.
View analysts' price targets for Mettler-Toledo International or view top-rated stocks among Wall Street analysts.

Mettler-Toledo International's stock was trading at $1,697.21 on January 1st, 2022. Since then, MTD shares have decreased by 32.4% and is now trading at $1,146.90.
View the best growth stocks for 2022 here.

Mettler-Toledo International saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 391,300 shares, a drop of 23.0% from the April 30th total of 508,500 shares. Based on an average trading volume of 132,600 shares, the days-to-cover ratio is presently 3.0 days. Currently, 1.8% of the company's stock are sold short.
View Mettler-Toledo International's Short Interest.

Mettler-Toledo International is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for Mettler-Toledo International.

Mettler-Toledo International Inc. (NYSE:MTD) announced its quarterly earnings data on Thursday, May, 5th. The medical instruments supplier reported $7.87 earnings per share for the quarter, topping analysts' consensus estimates of $7.32 by $0.55. The medical instruments supplier earned $897.80 million during the quarter, compared to analysts' expectations of $868.08 million. Mettler-Toledo International had a net margin of 20.82% and a trailing twelve-month return on equity of 540.97%. The company's revenue for the quarter was up 11.6% on a year-over-year basis. During the same period last year, the company earned $6.56 EPS.
View Mettler-Toledo International's earnings history.

Mettler-Toledo International issued an update on its second quarter 2022 earnings guidance on Thursday, May, 26th. The company provided earnings per share (EPS) guidance of $8.70-$8.80 for the period, compared to the consensus estimate of $8.80. The company issued revenue guidance of $989.06 million-$989.06 million, compared to the consensus revenue estimate of $946.77 million.

224 employees have rated Mettler-Toledo International CEO Olivier A. Filliol on Glassdoor.com. Olivier A. Filliol has an approval rating of 88% among Mettler-Toledo International's employees.

Some companies that are related to Mettler-Toledo International include Thermo Fisher Scientific (TMO), Agilent Technologies (A), Illumina (ILMN), Waters (WAT), PerkinElmer (PKI), Bio-Rad Laboratories (BIO), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), aTyr Pharma (LIFE) and BG Medicine (BGMD).
View all of MTD's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Mettler-Toledo International investors own include Intuitive Surgical (ISRG), NVIDIA (NVDA), Home Depot (HD), Adobe (ADBE), AbbVie (ABBV), Johnson & Johnson (JNJ), Northrop Grumman (NOC), Alibaba Group (BABA), Lockheed Martin (LMT) and Broadcom (AVGO).

Mettler-Toledo International trades on the New York Stock Exchange (NYSE) under the ticker symbol "MTD."

Mettler-Toledo International's stock is owned by a number of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (11.14%), BlackRock Inc. (9.36%), WCM Investment Management LLC (6.25%), State Street Corp (4.37%), Capital International Investors (2.60%) and Fiera Capital Corp (2.47%). Company insiders that own Mettler-Toledo International stock include Christian Magloth, Gerry Keller, La Guerroniere Marc De, Michael Heidingsfelder, Oliver A Filliol, Olivier A Filliol, Patrick Kaltenbach, Peter Aggersbjerg, Robert F Spoerry, Robert F Spoerry, Shawn Vadala, Simon Kirk, Thomas P Salice and Wah-Hui Chu.
View institutional ownership trends for Mettler-Toledo International.

MTD stock was sold by a variety of institutional investors in the last quarter, including Principal Financial Group Inc., SkyView Investment Advisors LLC, WCM Investment Management LLC, Baillie Gifford & Co., Fiera Capital Corp, Acadian Asset Management LLC, JPMorgan Chase & Co., and American Century Companies Inc.. Company insiders that have sold Mettler-Toledo International company stock in the last two years include Christian Magloth, Gerry Keller, La Guerroniere Marc De, Oliver A Filliol, Olivier A Filliol, Peter Aggersbjerg, Robert F Spoerry, Shawn Vadala, Thomas P Salice, and Wah-Hui Chu.
View insider buying and selling activity for Mettler-Toledo International or view top insider-selling stocks.

MTD stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Capital International Investors, First Trust Advisors LP, Achmea Investment Management B.V., Renaissance Technologies LLC, Vanguard Group Inc., Invesco Ltd., and National Bank of Canada FI.
View insider buying and selling activity for Mettler-Toledo International or or view top insider-buying stocks.

Shares of MTD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MTD stock can currently be purchased for approximately $1,146.90.

Mettler-Toledo International (NYSE:MTD) has a market capitalization of $26.08 billion and generates $3.72 billion in revenue each year. The medical instruments supplier earns $768.98 million in net income (profit) each year or $34.049990 on an earnings per share basis.

Mettler-Toledo International employs 17,800 workers across the globe.

Mettler-Toledo International was founded in 1946.

Mettler-Toledo International's mailing address is 1900 POLARIS PARKWAY, COLUMBUS OH, 43240. The official website for Mettler-Toledo International is www.mt.com. The medical instruments supplier can be reached via phone at (614) 438-4748, via email at [email protected], or via fax at 614-438-4900.